Topical Review: MACI as an Emerging Technology for the Treatment of Talar Osteochondral Lesions.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 28670917.
- Also identified by DOI 10.1177/1071100717711482.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Matrix-induced autologous chondrocyte implantation (MACI) is a viable procedure that can be used as both a primary or revision cartilage regenerative procedure in high-functioning individuals without tibiotalar arthritis. Both short-term and midterm follow-up results demonstrate clinical, radiographic, and functional improvements with high rates of return to full activities. Cost remains a chief concern with the use of this technique, but theoretical improvements in the durability of repair with type II cartilage replacement may offer long-term benefits. Level V, expert opinion.
Medical subject headings
- Cartilage, Articular
- Chondrocytes
- Transplantation, Autologous
Anatomy
- ankle